Biogen’s $200M expansion is another boost to NC’s growing biopharma sector
North Carolina’s gene and cell therapy magnet has attracted an investment from one of the state’s original biomanufacturers Biogen.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
